Veterans Affairs and Stanford Medicine announce intent to develop comprehensive cancer center
An anticipated growth in veterans seeking cancer care catalyzes talks to develop state-of-the-art collaboration between VA and Stanford Medicine.
Related Articles
Stanford students receive Paul & Daisy Soros Fellowships – Stanford Report
The award provides generous funding for immigrants and children of immigrants pursuing graduate degrees.
Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis
npj Digital Medicine – Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma – PubMed
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Although cSCC contributes to substantial morbidity and mortality in high-risk individuals, deployment of…
A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma
Background:In situ vaccination for the treatment of cancer aims to trigger an immune response locally that propagates systemically. We have shown that local tre
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
CRISPR technologies have begun to revolutionize T cell therapies; however, conventional CRISPR-Cas9 genome-editing tools are limited in their safety, …
Inosine induces stemness features in CAR-T cells and enhances potency
Adenosine (Ado) mediates immune suppression in the tumor microenvironment and exhausted CD8+ CAR-T cells express CD39 and CD73, which mediate proximal…
Stanford Cancer Institute Breakthroughs in Cancer: Philip Castle, PhD, MPH
Title: The Best Cancer Is The Cancer That Never HappensPhilip Castle, PhD, MPHDirector of the Division of Cancer PreventionNational Cancer InstituteLearn mor…
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix – PubMed
The addition of concurrent cisplatin-based CT to RT significantly improves progression-free and overall survival for high-risk, early-stage patients who undergo radical hysterectomy and pelvic lymphadenectomy…
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Nature – Structural changes mediated by advanced glycation end-products enhance extracellular matrix viscoelasticity, and that viscoelasticity can promote cancer progression in vivo, independent of…
Advances in translational research of the rare cancer type adrenocortical carcinoma – PubMed
Adrenocortical carcinoma is a rare malignancy with an annual worldwide incidence of 1-2 cases per 1 million and a 5-year survival rate of <60%. Although…